The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy

The aim of the research project discussed in this thesis was to study the inhibition of aerobic glycolysis, that is the metabolic pathway exploited by cancer cells for the ATP generation. This observation has led to the evaluation of glycolytic inhibitors as potential anticancer agents. Lactate dehy...

Full description

Bibliographic Details
Main Author: Vettraino, Marina Eleonora <1983>
Other Authors: Di Stefano, Giuseppina
Format: Doctoral Thesis
Language:en
Published: Alma Mater Studiorum - Università di Bologna 2014
Subjects:
Online Access:http://amsdottorato.unibo.it/6195/
id ndltd-unibo.it-oai-amsdottorato.cib.unibo.it-6195
record_format oai_dc
spelling ndltd-unibo.it-oai-amsdottorato.cib.unibo.it-61952014-04-04T04:48:37Z The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy Vettraino, Marina Eleonora <1983> MED/04 Patologia generale The aim of the research project discussed in this thesis was to study the inhibition of aerobic glycolysis, that is the metabolic pathway exploited by cancer cells for the ATP generation. This observation has led to the evaluation of glycolytic inhibitors as potential anticancer agents. Lactate dehydrogenase (LDH) is the only enzyme whose inhibition should allow a blocking of aerobic glycolysis of tumor cells without damaging the normal cells which, in conditions of normal functional activity and sufficient oxygen supply, do not need this enzyme. In preliminar experiments we demonstrated that oxamic acid and tartronic acid, two LDH competitive inhibitors, impaired aerobic glycolysis and replication of cells from human hepatocellular carcinoma. Therefore, we proposed that the depletion of ATP levels in neoplastic cells, could improved the chemotherapeutic index of associated anticancer drugs; in particular, it was studied the association of oxamic acid and multi-targeted kinase inhibitors. A synergistic effect in combination with sorafenib was observed, and we demonstrated that this was related to the capacity of sorafenib to hinder the oxidative phosphorylation, so that cells were more dependent to aerobic glycolysis. These results linked to LDH blockage encouraged us to search for LDH inhibitors more powerful than oxamic acid; thus, in collaboration with the Department of Pharmaceutical Sciences of Bologna University we identified a new molecule, galloflavin, able to inhibit both A and B isoforms of LDH enzyme. The effects of galloflavin were studied on different human cancer cell lines (hepatocellular carcinoma, breast cancer, Burkitt’s lymphoma). Although exhibiting different power on the tested cell lines, galloflavin was constantly found to inhibit lactate and ATP production and to induce cell death, mainly in the form of apoptosis. Finally, as LDH-A is able to bind single stranded DNA, thus stimulating cell transcription, galloflavin effects were also studied on this other LDH function. Alma Mater Studiorum - Università di Bologna Di Stefano, Giuseppina 2014-01-23 Doctoral Thesis PeerReviewed application/pdf en http://amsdottorato.unibo.it/6195/ info:eu-repo/semantics/openAccess
collection NDLTD
language en
format Doctoral Thesis
sources NDLTD
topic MED/04 Patologia generale
spellingShingle MED/04 Patologia generale
Vettraino, Marina Eleonora <1983>
The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
description The aim of the research project discussed in this thesis was to study the inhibition of aerobic glycolysis, that is the metabolic pathway exploited by cancer cells for the ATP generation. This observation has led to the evaluation of glycolytic inhibitors as potential anticancer agents. Lactate dehydrogenase (LDH) is the only enzyme whose inhibition should allow a blocking of aerobic glycolysis of tumor cells without damaging the normal cells which, in conditions of normal functional activity and sufficient oxygen supply, do not need this enzyme. In preliminar experiments we demonstrated that oxamic acid and tartronic acid, two LDH competitive inhibitors, impaired aerobic glycolysis and replication of cells from human hepatocellular carcinoma. Therefore, we proposed that the depletion of ATP levels in neoplastic cells, could improved the chemotherapeutic index of associated anticancer drugs; in particular, it was studied the association of oxamic acid and multi-targeted kinase inhibitors. A synergistic effect in combination with sorafenib was observed, and we demonstrated that this was related to the capacity of sorafenib to hinder the oxidative phosphorylation, so that cells were more dependent to aerobic glycolysis. These results linked to LDH blockage encouraged us to search for LDH inhibitors more powerful than oxamic acid; thus, in collaboration with the Department of Pharmaceutical Sciences of Bologna University we identified a new molecule, galloflavin, able to inhibit both A and B isoforms of LDH enzyme. The effects of galloflavin were studied on different human cancer cell lines (hepatocellular carcinoma, breast cancer, Burkitt’s lymphoma). Although exhibiting different power on the tested cell lines, galloflavin was constantly found to inhibit lactate and ATP production and to induce cell death, mainly in the form of apoptosis. Finally, as LDH-A is able to bind single stranded DNA, thus stimulating cell transcription, galloflavin effects were also studied on this other LDH function.
author2 Di Stefano, Giuseppina
author_facet Di Stefano, Giuseppina
Vettraino, Marina Eleonora <1983>
author Vettraino, Marina Eleonora <1983>
author_sort Vettraino, Marina Eleonora <1983>
title The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
title_short The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
title_full The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
title_fullStr The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
title_full_unstemmed The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
title_sort inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
publisher Alma Mater Studiorum - Università di Bologna
publishDate 2014
url http://amsdottorato.unibo.it/6195/
work_keys_str_mv AT vettrainomarinaeleonora1983 theinhibitionofaerobicglycolysisasatherapeuticapproachtoimprovecancerchemotherapy
AT vettrainomarinaeleonora1983 inhibitionofaerobicglycolysisasatherapeuticapproachtoimprovecancerchemotherapy
_version_ 1716662726599639040